CO Aurora의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 31개가 Aurora 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
피험자 모집 중1/2상
- University Of Colorado - Anschutz Medical Campus /ID# 269069, Aurora
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Rocky Mountain Cancer Centers-Aurora, Aurora
- UCHealth University of Colorado Hospital, Aurora
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- University of Colorado, Aurora
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
피험자 모집 중3상
- University of Colorado Anschutz Medical Campus ( Site 0151), Aurora
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
피험자 모집 중3상
- University of Colorado Cancer Center ( Site 3268), Aurora
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
피험자 모집 중3상
- Rocky Mountain Cancer Centers LLP, Aurora
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
피험자 모집 중1/2상
- Rocky Mountain Cancer Centers,LLP, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- University of Colorado Cancer Center, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- University of Colorado Cancer Center, Aurora
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
피험자 모집 중3상
- Clinical Study Site, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- University of Colorado - Aurora Cancer Center, Aurora
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
피험자 모집 중2/3상
- Local Institution - 007-872-H, Aurora
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- University of Colorado, Aurora
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
피험자 모집 중1/2상
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- University of Colorado Cancer Center, Aurora
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- University of Colorado Health Hospital, Aurora
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
피험자 모집 중1상
- University of Colorado Cancer Center, Aurora
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
피험자 모집 중3상
- University of Colorado Health, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- University of Colorado, Aurora
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
피험자 모집 중1/2상
- University of Colorado Cancer Center, Aurora
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
피험자 모집 중1상
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- UCHealth University of Colorado Hospital, Aurora
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
피험자 모집 중관찰 연구
- University of Colorado Hospital, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Rocky Mountain Regional VA Medical Center, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- UCHealth University of Colorado Hospital, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
피험자 모집 중1/2상
- University of Colorado Cancer Center, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
피험자 모집 중관찰 연구
- Rocky Mountain Cancer Centers-Aurora, Aurora
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
피험자 모집 중관찰 연구
- University of Colorado, Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Aurora
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
피험자 모집 중관찰 연구
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
피험자 모집 중1상
- University of Colorado School of Medicine, Aurora
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 121개
- Arlington, VA연구 104개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 57개
- Washington, DC연구 55개
Aurora의 다른 연구
- 암 (전체)연구 35개
- 대장직장암연구 32개
- 유방암연구 28개
- 난소암연구 25개
- 전이성 암연구 25개
- 제1형 당뇨병연구 23개
- 비만연구 22개
- 전립선암연구 19개
- 폐암연구 19개
- 심부전연구 18개
- 흑색종연구 18개
- 급성 골수성 백혈병연구 16개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.